| Literature DB >> 29619201 |
Dennis J Milanowski1, Naoya Oku1, Laura K Cartner1,2, Heidi R Bokesch1,2, R Thomas Williamson3, Josep Saurí3, Yizhou Liu3, Kirill A Blinov4, Yuanqing Ding5, Xing-Cong Li5, Daneel Ferreira5, Larry A Walker5, Shabana Khan5, Michael T Davies-Coleman6, James A Kelley7, James B McMahon1, Gary E Martin3, Kirk R Gustafson1.
Abstract
Ambiguities and errors in the structural assignment of organic molecules hinder both drug discovery and total synthesis efforts. Newly described NMR experimental approaches can provide valuable structural details and a complementary means of structure verification. The caulamidines are trihalogenated alkaloids from a marine bryozoan with an unprecedented structural scaffold. Their unique carbon and nitrogen framework was deduced by conventional NMR methods supplemented by new experiments that define 2-bond heteronuclear connectivities, reveal very long-range connectivity data, or visualize the 35,37Cl isotopic effect on chlorinated carbons. Computer-assisted structural elucidation (CASE) analysis of the spectroscopic data for caulamidine A provided only one viable structural alternative. Anisotropic NMR parameters, specifically residual dipolar coupling and residual chemical shift anisotropy data, were measured for caulamidine A and compared to DFT-calculated values for the proposed structure, the CASE-derived alternative structure, and two energetically feasible stereoisomers. Anisotropy-based NMR experiments provide a global, orthogonal means to verify complex structures free from investigator bias. The anisotropic NMR data were fully consistent with the assigned structure and configuration of caulamidine A. Caulamidine B has the same heterocyclic scaffold as A but a different composition and pattern of halogen substitution. Caulamidines A and B inhibited both wild-type and drug-resistant strains of the malaria parasite Plasmodium falciparum at low micromolar concentrations, yet were nontoxic to human cells.Entities:
Year: 2017 PMID: 29619201 PMCID: PMC5868047 DOI: 10.1039/c7sc01996c
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Structures of caulamidines A (1) and B (2).
NMR spectroscopic data for caulamidine A (1) in CD3CN
| Position |
|
|
| HMBC |
| 1-N | — | 78.9 | — | — |
| 2 | 174.0 | — | — | |
| 3-N | — | 241.7 | — | — |
| 4 | 156.0 | — | — | — |
| 5 | 117.8 | — | 7.17 (d, 8.5) | 3, 4, 6, 7, 9 |
| 6 | 129.4 | — | 7.31 (dd, 8.4, 2.0) | 4, 5, 7, 8 |
| 7 | 126.3 | — | — | — |
| 8 | 123.8 | — | 6.95 (bs) | 4, 6, 7, 10 |
| 9 | 133.3 | — | — | — |
| 10 | 58.9 | — | — | — |
| 11 | 54.8 | — | 5.02 (dd, 10.8, 4.7) | 2, 9, 10, 12, 23 |
| 12a | 52.6 | — | 3.87 (dd, 13.3, 6.6) | 11, 13, 14, 15, 27 |
| 12b | 3.66 (dd, 13.3, 10.5) | 11, 13, 14, 15 | ||
| 13-N | — | 87.5 | — | — |
| 14 | 159.1 | — | — | — |
| 15-N | — | 216.6 | — | — |
| 16 | 143.9 | — | — | — |
| 17 | 124.2 | — | 6.94 (d, 8.2) | 15, 16, 19, 21 |
| 18 | 127.2 | — | 7.12 (dd, 8.2, 2.4) | 16, 19 |
| 19 | 125.8 | — | — | — |
| 20 | 127.3 | — | 6.96 (s) | 16, 18, 19, 21, 22 |
| 21 | 125.4 | — | — | — |
| 22a | 29.6 | — | 2.48 (d, 15.9) | 10, 14, 16, 21, 23, 24 |
| 22b | 2.28 (d, 15.9) | 10, 13, 14, 16, 21, 23, 24 | ||
| 23 | 39.8 | — | — | — |
| 24a | 24.7 | — | 2.25 (m) | 10, 14, 22, 23, 25 |
| 24b | 1.73 (dd, 15.0, 6.2) | 1, 10, 22, 23, 25 | ||
| 25a | 47.4 | — | 3.38 (ddd, 12.5, 7.5, 1.6) | 2, 3, 24 |
| 25b | 3.18 (dt, 11.7, 5.9) | 24, 26 | ||
| 26 | 37.2 | — | 3.00, 3H (s) | 1, 2, 3, 25 |
| 27 | 35.8 | — | 3.24, 3H (s) | 12, 13, 14, 15 |
15N assignments were based on 1H–15N HMBC correlations. The δN values were not calibrated to an external standard but were referenced to neat NH3 (δ 0.00) using the standard Bruker parameters.
1H–13C (optimized for 8.3 Hz) and 1H–15N (optimized for 8 Hz) HMBC correlations are listed.
Fig. 2(A) and (B) Selected 1H–13C HMBC correlations for caulamidine A (1). (C) 1H–15N HMBC correlations. (D) Additional correlations in LR-HSQMBC with respect to 1H–13C HMBC (orange arrows) and additional correlations in HSQMBC-TOCSY with respect to LR-HSQMBC and HMBC (green arrows). (E) Key 1,1-HD-ADEQUATE correlations revealed quaternary carbons adjacent to protonated centers. (F) NOESY and ROESY correlations used to assign the relative configuration.
Fig. 3The 35,37Cl isotope effect observed in the bs-CLIP-HSQMBC experiment 1D 13C slices for C-7 and C-19 of caulamidine A (1). The isotope shifts of 5.1 and 4.6 ppb for C-7 and C-19 correspond to shifts of 0.77 and 0.69 Hz, respectively. While isotope effects of this magnitude have been observed in the past in 1D 13C NMR spectra, it is far easier to obtain the resolution to observe these effects using the bs-CLIP-HSQMBC experiment.
Fig. 4Experimental (exptl, blue) and computed ECD spectra of (10S,11S,23S)-caulamidine A at the B3LYP/6-31G** (gas, green) and B3LYP/6-311++G** (lbs, black) levels in the gas phase and at the B3LYP-SCRF(COSMO)/6-311++G**//B3LYP/6-311++G** (sol, red) level in MeOH.
Fig. 5Comparison of the experimental vs. DFT-calculated RDC (red) and RCSA (blue) values for caulamidine A (1), the CASE-generated alternative structure 3, and configurational isomers 4 and 5. The Q-value is a quantitative similarity measurement for the DFT-calculated RDC and RCSA values for the structure compared to the experimentally measured data. RDC values define the orientation of the C–H bond vectors for protonated carbons, whereas RCSAs describe the chemical shift tensors for all carbons in the molecule's skeleton.17 For proton-deficient molecules, RCSA data can provide a better assessment of global structural correctness than sparsely available RDCs.